Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Worthington Industries, Inc. (WOR) Surges 9%: Is It A Good Stock To Buy?

Page 1 of 2

Worthington Industries, Inc. (NYSE:WOR) jumped over 9% to as high as $30.97 per share today as the company reported profit and revenue in its fourth quarter which ended May 31 for the fiscal year 2015 that were higher than what analysts expected. According to the Columbus, Ohio-based company, net earnings for the fourth quarter was $28.9 million, or $0.44 per diluted share, on net sales of $846.0 million. This is down from the fourth quarter of the previous year, when the firm reported net earnings of $33.2 million, or $0.47 per diluted share, on net sales of $891.0 million. EPS was impacted by $6.5 million in charges, the company said, which reduced EPS by $0.08.

Without the charges, Worthington Industries would have had an EPS of $0.52 per share. Analysts expected the firm to report an EPS of $0.46 on net sales of $835.87 million, according to data from Thomson Reuters. For the full fiscal 2015 year, the company reported net earnings of $76.8 million, or $1.12 per diluted share, on net sales of $3.38 billion. Net sales were up 8%, or $257.8 million, from $3.13 billion last year. The firm has also announced a quarterly dividend of $0.19 per share, up $0.01 per share compared to the previous quarter. Aside from the beat for the fourth quarter and the increase in dividend, data from Insider Monkey reveals that there is an increase in hedge fund activity in Worthington Industries, Inc.

Insider Monkey tracks hedge fund activity and insider sentiment because most investors can’t outperform the stock market by individually picking stocks. Stock returns aren’t evenly distributed. A randomly picked stock has only a 35% to 45% chance (depending on the investment horizon) to outperform the market. There are a few exceptions, one of which is when it comes to purchases made by corporate insiders. Academic research has shown that certain insider purchases historically outperformed the market by an average of seven percentage points per year. This effect is more pronounced in small-cap stocks. Another exception is the small-cap stock picks of hedge funds. Our research has shown that the 15 most popular small-cap stocks among hedge funds outperformed the market by nearly a percentage point per month between 1999 and 2012. We have been forward testing the performance of these stock picks since the end of August 2012 and they have returned more than 144% over the ensuing 32 months, outperforming the S&P 500 Index by nearly 85 percentage points (read the details here). The trick is focusing only on the best small-cap stock picks of funds, not their large-cap stock picks which are extensively covered by analysts and followed by almost everybody.

In terms of insider sentiment about Worthington Industries, Inc. (NYSE:WOR), there were several purchase of shares by insiders in the first quarter. In transactions that all happened on January 15, Director John Blystone bought 10,000 shares, Director Michael Endres bought 40,000, Vice President of Mergers and Acquisitions Joseph Hayek bought 1,000 shares, Director Ozey Horton bought 1,000 shares and Director Mark Davis bought 3,000 shares. As for sales, President Geoffrey Gilmore sold 1,405 shares in April 13 and Director Sidney Ribeau sold 4,000 shares on April 16.

Keeping this in mind, we’re going to take a peek at the recent action encompassing Worthington Industries, Inc. (NYSE:WOR).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!